1 Study Coverage
1.1 Antibody Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Antibody Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monoclonal Antibodies
1.2.3 Antibody-Drug Conjugates
1.2.4 Polyclonal Antibodies
1.3 Market by Application
1.3.1 Global Antibody Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Central Nervous System (CNS) Disorders
1.3.3 Cancers
1.3.4 Autoimmune Disorders
1.3.5 Cardiovascular Diseases
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antibody Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Antibody Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Antibody Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antibody Drugs Sales by Region
2.4.1 Global Antibody Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Antibody Drugs by Region (2023-2028)
2.5 Global Antibody Drugs Revenue by Region
2.5.1 Global Antibody Drugs Revenue by Region (2017-2022)
2.5.2 Global Antibody Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antibody Drugs Sales by Manufacturers
3.1.1 Global Top Antibody Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Antibody Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antibody Drugs in 2021
3.2 Global Antibody Drugs Revenue by Manufacturers
3.2.1 Global Antibody Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Antibody Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Antibody Drugs Revenue in 2021
3.3 Global Antibody Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antibody Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antibody Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antibody Drugs Sales by Type
4.1.1 Global Antibody Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Antibody Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Antibody Drugs Sales Market Share by Type (2017-2028)
4.2 Global Antibody Drugs Revenue by Type
4.2.1 Global Antibody Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Antibody Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Antibody Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Antibody Drugs Price by Type
4.3.1 Global Antibody Drugs Price by Type (2017-2022)
4.3.2 Global Antibody Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Antibody Drugs Sales by Application
5.1.1 Global Antibody Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Antibody Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Antibody Drugs Sales Market Share by Application (2017-2028)
5.2 Global Antibody Drugs Revenue by Application
5.2.1 Global Antibody Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Antibody Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Antibody Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Antibody Drugs Price by Application
5.3.1 Global Antibody Drugs Price by Application (2017-2022)
5.3.2 Global Antibody Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antibody Drugs Market Size by Type
6.1.1 North America Antibody Drugs Sales by Type (2017-2028)
6.1.2 North America Antibody Drugs Revenue by Type (2017-2028)
6.2 North America Antibody Drugs Market Size by Application
6.2.1 North America Antibody Drugs Sales by Application (2017-2028)
6.2.2 North America Antibody Drugs Revenue by Application (2017-2028)
6.3 North America Antibody Drugs Market Size by Country
6.3.1 North America Antibody Drugs Sales by Country (2017-2028)
6.3.2 North America Antibody Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Antibody Drugs Market Size by Type
7.1.1 Europe Antibody Drugs Sales by Type (2017-2028)
7.1.2 Europe Antibody Drugs Revenue by Type (2017-2028)
7.2 Europe Antibody Drugs Market Size by Application
7.2.1 Europe Antibody Drugs Sales by Application (2017-2028)
7.2.2 Europe Antibody Drugs Revenue by Application (2017-2028)
7.3 Europe Antibody Drugs Market Size by Country
7.3.1 Europe Antibody Drugs Sales by Country (2017-2028)
7.3.2 Europe Antibody Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antibody Drugs Market Size by Type
8.1.1 Asia Pacific Antibody Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Antibody Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Antibody Drugs Market Size by Application
8.2.1 Asia Pacific Antibody Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Antibody Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Antibody Drugs Market Size by Region
8.3.1 Asia Pacific Antibody Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Antibody Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Antibody Drugs Market Size by Type
9.1.1 Latin America Antibody Drugs Sales by Type (2017-2028)
9.1.2 Latin America Antibody Drugs Revenue by Type (2017-2028)
9.2 Latin America Antibody Drugs Market Size by Application
9.2.1 Latin America Antibody Drugs Sales by Application (2017-2028)
9.2.2 Latin America Antibody Drugs Revenue by Application (2017-2028)
9.3 Latin America Antibody Drugs Market Size by Country
9.3.1 Latin America Antibody Drugs Sales by Country (2017-2028)
9.3.2 Latin America Antibody Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antibody Drugs Market Size by Type
10.1.1 Middle East and Africa Antibody Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Antibody Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Antibody Drugs Market Size by Application
10.2.1 Middle East and Africa Antibody Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Antibody Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Antibody Drugs Market Size by Country
10.3.1 Middle East and Africa Antibody Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Antibody Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Overview
11.2.3 Amgen Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Amgen Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Corporation Information
11.3.2 Bristol-Myers Squibb Overview
11.3.3 Bristol-Myers Squibb Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bristol-Myers Squibb Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Corporation Information
11.4.2 F. Hoffmann-La Roche Overview
11.4.3 F. Hoffmann-La Roche Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 F. Hoffmann-La Roche Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 F. Hoffmann-La Roche Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Overview
11.5.3 Johnson & Johnson Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Johnson & Johnson Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Johnson & Johnson Recent Developments
11.6 AbbVie
11.6.1 AbbVie Corporation Information
11.6.2 AbbVie Overview
11.6.3 AbbVie Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 AbbVie Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 AbbVie Recent Developments
11.7 Eli Lilly
11.7.1 Eli Lilly Corporation Information
11.7.2 Eli Lilly Overview
11.7.3 Eli Lilly Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Eli Lilly Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Eli Lilly Recent Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pfizer Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 Bayer
11.9.1 Bayer Corporation Information
11.9.2 Bayer Overview
11.9.3 Bayer Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Bayer Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Bayer Recent Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Corporation Information
11.10.2 GlaxoSmithKline Overview
11.10.3 GlaxoSmithKline Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 GlaxoSmithKline Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 GlaxoSmithKline Recent Developments
11.11 Sanofi
11.11.1 Sanofi Corporation Information
11.11.2 Sanofi Overview
11.11.3 Sanofi Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sanofi Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sanofi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antibody Drugs Industry Chain Analysis
12.2 Antibody Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antibody Drugs Production Mode & Process
12.4 Antibody Drugs Sales and Marketing
12.4.1 Antibody Drugs Sales Channels
12.4.2 Antibody Drugs Distributors
12.5 Antibody Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antibody Drugs Industry Trends
13.2 Antibody Drugs Market Drivers
13.3 Antibody Drugs Market Challenges
13.4 Antibody Drugs Market Restraints
14 Key Findings in The Global Antibody Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Antibody Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibodies
Table 3. Major Manufacturers of Antibody-Drug Conjugates
Table 4. Major Manufacturers of Polyclonal Antibodies
Table 5. Global Antibody Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Antibody Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Antibody Drugs Sales by Region (2017-2022) & (mg)
Table 8. Global Antibody Drugs Sales Market Share by Region (2017-2022)
Table 9. Global Antibody Drugs Sales by Region (2023-2028) & (mg)
Table 10. Global Antibody Drugs Sales Market Share by Region (2023-2028)
Table 11. Global Antibody Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Antibody Drugs Revenue Market Share by Region (2017-2022)
Table 13. Global Antibody Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Antibody Drugs Revenue Market Share by Region (2023-2028)
Table 15. Global Antibody Drugs Sales by Manufacturers (2017-2022) & (mg)
Table 16. Global Antibody Drugs Sales Share by Manufacturers (2017-2022)
Table 17. Global Antibody Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Antibody Drugs Revenue Share by Manufacturers (2017-2022)
Table 19. Antibody Drugs Price by Manufacturers (2017-2022) &(USD/mg)
Table 20. Global Antibody Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Antibody Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drugs as of 2021)
Table 22. Antibody Drugs Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Antibody Drugs Product Offered
Table 24. Date of Manufacturers Enter into Antibody Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Antibody Drugs Sales by Type (2017-2022) & (mg)
Table 27. Global Antibody Drugs Sales by Type (2023-2028) & (mg)
Table 28. Global Antibody Drugs Sales Share by Type (2017-2022)
Table 29. Global Antibody Drugs Sales Share by Type (2023-2028)
Table 30. Global Antibody Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Antibody Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Antibody Drugs Revenue Share by Type (2017-2022)
Table 33. Global Antibody Drugs Revenue Share by Type (2023-2028)
Table 34. Antibody Drugs Price by Type (2017-2022) & (USD/mg)
Table 35. Global Antibody Drugs Price Forecast by Type (2023-2028) & (USD/mg)
Table 36. Global Antibody Drugs Sales by Application (2017-2022) & (mg)
Table 37. Global Antibody Drugs Sales by Application (2023-2028) & (mg)
Table 38. Global Antibody Drugs Sales Share by Application (2017-2022)
Table 39. Global Antibody Drugs Sales Share by Application (2023-2028)
Table 40. Global Antibody Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Antibody Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Antibody Drugs Revenue Share by Application (2017-2022)
Table 43. Global Antibody Drugs Revenue Share by Application (2023-2028)
Table 44. Antibody Drugs Price by Application (2017-2022) & (USD/mg)
Table 45. Global Antibody Drugs Price Forecast by Application (2023-2028) & (USD/mg)
Table 46. North America Antibody Drugs Sales by Type (2017-2022) & (mg)
Table 47. North America Antibody Drugs Sales by Type (2023-2028) & (mg)
Table 48. North America Antibody Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Antibody Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Antibody Drugs Sales by Application (2017-2022) & (mg)
Table 51. North America Antibody Drugs Sales by Application (2023-2028) & (mg)
Table 52. North America Antibody Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Antibody Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Antibody Drugs Sales by Country (2017-2022) & (mg)
Table 55. North America Antibody Drugs Sales by Country (2023-2028) & (mg)
Table 56. North America Antibody Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Antibody Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Antibody Drugs Sales by Type (2017-2022) & (mg)
Table 59. Europe Antibody Drugs Sales by Type (2023-2028) & (mg)
Table 60. Europe Antibody Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Antibody Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Antibody Drugs Sales by Application (2017-2022) & (mg)
Table 63. Europe Antibody Drugs Sales by Application (2023-2028) & (mg)
Table 64. Europe Antibody Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Antibody Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Antibody Drugs Sales by Country (2017-2022) & (mg)
Table 67. Europe Antibody Drugs Sales by Country (2023-2028) & (mg)
Table 68. Europe Antibody Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Antibody Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Antibody Drugs Sales by Type (2017-2022) & (mg)
Table 71. Asia Pacific Antibody Drugs Sales by Type (2023-2028) & (mg)
Table 72. Asia Pacific Antibody Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Antibody Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Antibody Drugs Sales by Application (2017-2022) & (mg)
Table 75. Asia Pacific Antibody Drugs Sales by Application (2023-2028) & (mg)
Table 76. Asia Pacific Antibody Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Antibody Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Antibody Drugs Sales by Region (2017-2022) & (mg)
Table 79. Asia Pacific Antibody Drugs Sales by Region (2023-2028) & (mg)
Table 80. Asia Pacific Antibody Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Antibody Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Antibody Drugs Sales by Type (2017-2022) & (mg)
Table 83. Latin America Antibody Drugs Sales by Type (2023-2028) & (mg)
Table 84. Latin America Antibody Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Antibody Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Antibody Drugs Sales by Application (2017-2022) & (mg)
Table 87. Latin America Antibody Drugs Sales by Application (2023-2028) & (mg)
Table 88. Latin America Antibody Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Antibody Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Antibody Drugs Sales by Country (2017-2022) & (mg)
Table 91. Latin America Antibody Drugs Sales by Country (2023-2028) & (mg)
Table 92. Latin America Antibody Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Antibody Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Antibody Drugs Sales by Type (2017-2022) & (mg)
Table 95. Middle East and Africa Antibody Drugs Sales by Type (2023-2028) & (mg)
Table 96. Middle East and Africa Antibody Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Antibody Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Antibody Drugs Sales by Application (2017-2022) & (mg)
Table 99. Middle East and Africa Antibody Drugs Sales by Application (2023-2028) & (mg)
Table 100. Middle East and Africa Antibody Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Antibody Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Antibody Drugs Sales by Country (2017-2022) & (mg)
Table 103. Middle East and Africa Antibody Drugs Sales by Country (2023-2028) & (mg)
Table 104. Middle East and Africa Antibody Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Antibody Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 106. Novartis Corporation Information
Table 107. Novartis Description and Major Businesses
Table 108. Novartis Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2017-2022)
Table 109. Novartis Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Novartis Recent Developments
Table 111. Amgen Corporation Information
Table 112. Amgen Description and Major Businesses
Table 113. Amgen Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2017-2022)
Table 114. Amgen Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Amgen Recent Developments
Table 116. Bristol-Myers Squibb Corporation Information
Table 117. Bristol-Myers Squibb Description and Major Businesses
Table 118. Bristol-Myers Squibb Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2017-2022)
Table 119. Bristol-Myers Squibb Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Bristol-Myers Squibb Recent Developments
Table 121. F. Hoffmann-La Roche Corporation Information
Table 122. F. Hoffmann-La Roche Description and Major Businesses
Table 123. F. Hoffmann-La Roche Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2017-2022)
Table 124. F. Hoffmann-La Roche Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. F. Hoffmann-La Roche Recent Developments
Table 126. Johnson & Johnson Corporation Information
Table 127. Johnson & Johnson Description and Major Businesses
Table 128. Johnson & Johnson Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2017-2022)
Table 129. Johnson & Johnson Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Johnson & Johnson Recent Developments
Table 131. AbbVie Corporation Information
Table 132. AbbVie Description and Major Businesses
Table 133. AbbVie Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2017-2022)
Table 134. AbbVie Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. AbbVie Recent Developments
Table 136. Eli Lilly Corporation Information
Table 137. Eli Lilly Description and Major Businesses
Table 138. Eli Lilly Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2017-2022)
Table 139. Eli Lilly Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Eli Lilly Recent Developments
Table 141. Pfizer Corporation Information
Table 142. Pfizer Description and Major Businesses
Table 143. Pfizer Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2017-2022)
Table 144. Pfizer Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Pfizer Recent Developments
Table 146. Bayer Corporation Information
Table 147. Bayer Description and Major Businesses
Table 148. Bayer Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2017-2022)
Table 149. Bayer Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Bayer Recent Developments
Table 151. GlaxoSmithKline Corporation Information
Table 152. GlaxoSmithKline Description and Major Businesses
Table 153. GlaxoSmithKline Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2017-2022)
Table 154. GlaxoSmithKline Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. GlaxoSmithKline Recent Developments
Table 156. Sanofi Corporation Information
Table 157. Sanofi Description and Major Businesses
Table 158. Sanofi Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2017-2022)
Table 159. Sanofi Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Sanofi Recent Developments
Table 161. Key Raw Materials Lists
Table 162. Raw Materials Key Suppliers Lists
Table 163. Antibody Drugs Distributors List
Table 164. Antibody Drugs Customers List
Table 165. Antibody Drugs Market Trends
Table 166. Antibody Drugs Market Drivers
Table 167. Antibody Drugs Market Challenges
Table 168. Antibody Drugs Market Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody Drugs Product Picture
Figure 3. Global Antibody Drugs Market Share by Type in 2021 & 2028
Figure 3. Monoclonal Antibodies Product Picture
Figure 4. Antibody-Drug Conjugates Product Picture
Figure 5. Polyclonal Antibodies Product Picture
Figure 6. Global Antibody Drugs Market Share by Application in 2021 & 2028
Figure 7. Central Nervous System (CNS) Disorders
Figure 8. Cancers
Figure 9. Autoimmune Disorders
Figure 10. Cardiovascular Diseases
Figure 11. Antibody Drugs Report Years Considered
Figure 12. Global Antibody Drugs Sales 2017-2028 (mg)
Figure 13. Global Antibody Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Antibody Drugs Revenue 2017-2028 (US$ Million)
Figure 15. Global Antibody Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Antibody Drugs Sales Market Share by Region (2017-2022)
Figure 17. Global Antibody Drugs Sales Market Share by Region (2023-2028)
Figure 18. North America Antibody Drugs Sales YoY (2017-2028) & (mg)
Figure 19. North America Antibody Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Antibody Drugs Sales YoY (2017-2028) & (mg)
Figure 21. Europe Antibody Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Antibody Drugs Sales YoY (2017-2028) & (mg)
Figure 23. Asia-Pacific Antibody Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Antibody Drugs Sales YoY (2017-2028) & (mg)
Figure 25. Latin America Antibody Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Antibody Drugs Sales YoY (2017-2028) & (mg)
Figure 27. Middle East & Africa Antibody Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Antibody Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Antibody Drugs in the World: Market Share by Antibody Drugs Revenue in 2021
Figure 30. Global Antibody Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Antibody Drugs Sales Market Share by Type (2017-2028)
Figure 32. Global Antibody Drugs Revenue Market Share by Type (2017-2028)
Figure 33. Global Antibody Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Antibody Drugs Revenue Market Share by Application (2017-2028)
Figure 35. North America Antibody Drugs Sales Market Share by Type (2017-2028)
Figure 36. North America Antibody Drugs Revenue Market Share by Type (2017-2028)
Figure 37. North America Antibody Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Antibody Drugs Revenue Market Share by Application (2017-2028)
Figure 39. North America Antibody Drugs Sales Share by Country (2017-2028)
Figure 40. North America Antibody Drugs Revenue Share by Country (2017-2028)
Figure 41. U.S. Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Antibody Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Antibody Drugs Revenue Market Share by Type (2017-2028)
Figure 45. Europe Antibody Drugs Sales Market Share by Application (2017-2028)
Figure 46. Europe Antibody Drugs Revenue Market Share by Application (2017-2028)
Figure 47. Europe Antibody Drugs Sales Share by Country (2017-2028)
Figure 48. Europe Antibody Drugs Revenue Share by Country (2017-2028)
Figure 49. Germany Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. France Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Antibody Drugs Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Antibody Drugs Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Antibody Drugs Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Antibody Drugs Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Antibody Drugs Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Antibody Drugs Revenue Share by Region (2017-2028)
Figure 60. China Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. India Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Antibody Drugs Sales Market Share by Type (2017-2028)
Figure 71. Latin America Antibody Drugs Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Antibody Drugs Sales Market Share by Application (2017-2028)
Figure 73. Latin America Antibody Drugs Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Antibody Drugs Sales Share by Country (2017-2028)
Figure 75. Latin America Antibody Drugs Revenue Share by Country (2017-2028)
Figure 76. Mexico Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Antibody Drugs Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Antibody Drugs Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Antibody Drugs Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Antibody Drugs Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Antibody Drugs Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Antibody Drugs Revenue Share by Country (2017-2028)
Figure 85. Turkey Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 87. U.A.E Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 88. Antibody Drugs Value Chain
Figure 89. Antibody Drugs Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
